Market Place
Sourcing Support
Onco360 Named National Pharmacy Partner for Itovebi™
11 Nov 2024 //
GLOBENEWSWIRE
Onco360 Selected As Partner For Tevimbra
04 Oct 2024 //
GLOBENEWSWIRE
LAZCLUZE Now Available From Onco360 For Metastatic NSCLC Treatment
30 Aug 2024 //
GLOBENEWSWIRE
Onco360 Selected As National Pharmacy Partner For VORANIGO
12 Aug 2024 //
GLOBENEWSWIRE
Onco360 Named Limited Distribution Partner For Rytelo™ (Imetelstat)
12 Jul 2024 //
GLOBENEWSWIRE
BrightSpring Selects Onco360 As National Pharmacy Partner
20 May 2024 //
GLOBENEWSWIRE
BrightSpring Health Services` Onco360® Selected as National Pharmacy Partner
10 Apr 2024 //
GLOBENEWSWIRE
Onco360® Celebrates Excellent Patient Care and Preferred Pharmacy Status
14 Mar 2024 //
GLOBENEWSWIRE
Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO
13 Mar 2024 //
BUSINESSWIRE
FABHALTA Now Available from Onco360 for the Treatment of PNH
20 Dec 2023 //
BUSINESSWIRE
OGSIVEO Available from Onco360 as First and Only Treatment for Desmoid Tumors
30 Nov 2023 //
BUSINESSWIRE
TRUQAP™ (capivasertib) Now Available from Onco360
29 Nov 2023 //
BUSINESSWIRE
FRUZAQLA™ (fruquintinib) Now Available from Onco360
21 Nov 2023 //
BUSINESSWIRE
AKEEGA™ (niraparib and abiraterone acetate) Now Available from Onco360
03 Oct 2023 //
BUSINESSWIRE
OJJAARA™ (momelotinib) Now Available from Onco360 For MF
25 Sep 2023 //
BUSINESSWIRE
ELREXFIO™ (elranatamab-bcmm), Now Available from Onco360
13 Sep 2023 //
BUSINESSWIRE
VANFLYTA® (quizartinib) Now Available from Onco360
09 Aug 2023 //
BUSINESSWIRE
Lytgobi Now Available from Onco360 for the Treatment of Adult Patients
13 Feb 2023 //
BUSINESSWIRE
ORSERDU Now Available from Onco360 for the Treatment of Postmenopausal Women
02 Feb 2023 //
BUSINESSWIRE
JAYPIRCA™ (pirtobrutinib) Now Available from Onco360 for the Treatment of MCL
01 Feb 2023 //
BUSINESSWIRE
KRAZATI Available from Onco360 for the Treatment of NSCLC
15 Dec 2022 //
BUSINESSWIRE
TIBSOVO Available from Onco360 for the Treatment of IDH1-mutant AML
15 Sep 2022 //
BUSINESSWIRE
ORGOVYX Now Available from Onco360 for Advanced Prostate Cancer
06 Jun 2022 //
BUSINESSWIRE
VONJO Approved for Myelofibrosis with Platelet Count Below 50 x 109/L
04 Mar 2022 //
BUSINESSWIRE
Onco360® Selected by Merck & Co., Inc. to Be in Pharmacy Network for WELIREG™
19 Aug 2021 //
BUSINESSWIRE
REZUROCK Tablets Approved to Treat Chronic Graft-Versus-Host Disease
21 Jul 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.